Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Top Biotech Stocks to Buy in May

TheMotleyFool

0 0

Mounting uncertainty over the potential for a global recession led the S&P 500 index to fall into a bear market on May 20. But not all stocks have fared poorly.

Pharma stocks Merck (NYSE: MRK) and Johnson & Johnson (NYSE: JNJ) have gained 23% and 5%, respectively, year to date. And based on their valuations, the two stocks look like solid long-term buys right now.

Merck's $233 billion market capitalization positions it as the fifth-largest pharma stock in the world. The company has an excellent drug portfolio and pipeline that should bode well for the future.

Source Fool.com

Like: 0

MRK

Share